Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 3, 2012, Pages 707-711

  Riaz, Nadeem ^a   Afaq, Asim ^a   Akin, Oguz ^a   Pei, Xin ^a   Kollmeier, Marisa A ^a   Cox, Brett ^a   Hricak, Hedvig ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Biochemical control; Brachytherapy; Endorectal coil MRI; Intensity modulated radiotherapy; Prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; BIOCHEMICAL CONTROL; BIOCHEMICAL FAILURE; BIOCHEMICAL RELAPSE-FREE SURVIVAL; BRACHYTHERAPY; GLEASON SCORES; HAZARD RATIO; IMAGE-BASED; INDEPENDENT PREDICTORS; INTENSITY-MODULATED RADIOTHERAPY; MULTI VARIATE ANALYSIS; PRE-TREATMENT; PROSTATE CANCERS; TUMOR CONTROL; TUMOR SIZE; UNIVARIATE ANALYSIS;

DISEASES; FORECASTING; MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATIENT MONITORING; TUMORS;

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL TUMOR CONTROL; BRACHYTHERAPY; CANCER CONTROL; CANCER RELAPSE; CLINICAL ASSESSMENT; ENDORECTAL COIL MAGNETIC RESONANCE IMAGING; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIODIAGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RISK ASSESSMENT; TUMOR LOCALIZATION; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84866740003     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.009     Document Type: Article

References (19)

1. P.L. Ross, P.T. Scardino, and M.W. Kattan A catalog of prostate cancer nomograms J Urol 165 2001 1562 1568
2. S.F. Shariat, P.I. Karakiewicz, and C.G. Roehrborn An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075 3099
3. O. Akin, and H. Hricak Imaging of prostate cancer Radiol Clin North Am 45 2007 207 222
4. M.R. Engelbrecht, G.J. Jager, and R.J. Laheij Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis Eur Radiol 12 2002 2294 2302
5. M. Mullerad, H. Hricak, and L. Wang Prostate cancer: Detection of extracapsular extension by genitourinary and general body radiologists at MR imaging Radiology 232 2004 140 146
6. L. Wang, H. Hricak, and M.W. Kattan Prediction of organ-confined prostate cancer: Incremental value of MR imaging and MR spectroscopic imaging to staging nomograms Radiology 238 2006 597 603
7. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer Urology 55 2000 572 577
8. M.H. Fuchsjager, A. Shukla-Dave, and H. Hricak Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy BJU Int 104 2009 315 320
9. M.H. Fuchsjager, D. Pucar, and M.J. Zelefsky Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI Int J Radiat Oncol Biol Phys 78 2010 743 750
10. D.A. McKenna, F.V. Coakley, and A.C. Westphalen Prostate cancer: Role of pretreatment MR in predicting outcome after external-beam radiation therapy - initial experience Radiology 247 2008 141 146
11. T. Joseph, D.A. McKenna, and A.C. Westphalen Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy Int J Radiat Oncol Biol Phys 73 2009 665 671
12. P.L. Nguyen, R. Whittington, and S. Koo Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 400 405
13. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
14. Kollmeier MA, Pei X, Algur E, et al. A comparison of the impact of isotope ((125)I vs (103)Pd) on toxicity and biochemical outcome following interstitial brachytherapy and external beam radiation therapy for clinically localized prostate cancer. Brachytherapy. In press.
15. H. Zou, and T. Hastie Regularization and variable selection via the elastic net J R Stat Soc B 67 2005 301 320
16. T.A. Stamey, J.E. McNeal, and C.M. Yemoto Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400
17. G.W. Hull, F. Rabbani, and F. Abbas Cancer control with radical prostatectomy alone in 1,000 consecutive patients J Urol 167 2002 528 534
18. M. Han, A.W. Partin, and M. Zahurak Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 2003 517 523
19. C.K. Kim, B.K. Park, and H.M. Lee Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion-weighted MRI J Magn Reson Imaging 29 2009 391 397